Literature DB >> 19701185

Sustained cyclic AMP production by parathyroid hormone receptor endocytosis.

Sébastien Ferrandon1, Timothy N Feinstein, Marian Castro, Bin Wang, Richard Bouley, John T Potts, Thomas J Gardella, Jean-Pierre Vilardaga.   

Abstract

Cell signaling mediated by the G protein-coupled parathyroid hormone receptor type 1 (PTHR) is fundamental to bone and kidney physiology. It has been unclear how the two ligand systems--PTH, endocrine and homeostatic, and PTH-related peptide (PTHrP), paracrine--can effectively operate with only one receptor and trigger different durations of the cAMP responses. Here we analyze the ligand response by measuring the kinetics of activation and deactivation for each individual reaction step along the PTHR signaling cascade. We found that during the time frame of G protein coupling and cAMP production, PTHrP(1-36) action was restricted to the cell surface, whereas PTH(1-34) had moved to internalized compartments where it remained associated with the PTHR and Galpha(s), potentially as a persistent and active ternary complex. Such marked differences suggest a mechanism by which PTH and PTHrP induce differential responses, and these results indicate that the central tenet that cAMP production originates exclusively at the cell membrane must be revised.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19701185      PMCID: PMC3032084          DOI: 10.1038/nchembio.206

Source DB:  PubMed          Journal:  Nat Chem Biol        ISSN: 1552-4450            Impact factor:   15.040


  22 in total

1.  A highly effective dominant negative alpha s construct containing mutations that affect distinct functions inhibits multiple Gs-coupled receptor signaling pathways.

Authors:  Catherine H Berlot
Journal:  J Biol Chem       Date:  2002-04-01       Impact factor: 5.157

Review 2.  Seven-transmembrane receptors.

Authors:  Kristen L Pierce; Richard T Premont; Robert J Lefkowitz
Journal:  Nat Rev Mol Cell Biol       Date:  2002-09       Impact factor: 94.444

3.  Novel single chain cAMP sensors for receptor-induced signal propagation.

Authors:  Viacheslav O Nikolaev; Moritz Bünemann; Lutz Hein; Annette Hannawacker; Martin J Lohse
Journal:  J Biol Chem       Date:  2004-07-01       Impact factor: 5.157

4.  Prolonged signaling at the parathyroid hormone receptor by peptide ligands targeted to a specific receptor conformation.

Authors:  Makoto Okazaki; Sebastien Ferrandon; Jean-Pierre Vilardaga; Mary L Bouxsein; John T Potts; Thomas J Gardella
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-22       Impact factor: 11.205

5.  Direct comparison of sustained infusion of human parathyroid hormone-related protein-(1-36) [hPTHrP-(1-36)] versus hPTH-(1-34) on serum calcium, plasma 1,25-dihydroxyvitamin D concentrations, and fractional calcium excretion in healthy human volunteers.

Authors:  Mara J Horwitz; Mary Beth Tedesco; Susan M Sereika; Bruce W Hollis; Adolfo Garcia-Ocaña; Andrew F Stewart
Journal:  J Clin Endocrinol Metab       Date:  2003-04       Impact factor: 5.958

6.  Reliable and global measurement of fluorescence resonance energy transfer using fluorescence microscopes.

Authors:  Z Xia; Y Liu
Journal:  Biophys J       Date:  2001-10       Impact factor: 4.033

7.  Parathyroid hormone receptor recycling: role of receptor dephosphorylation and beta-arrestin.

Authors:  Stephanie Chauvin; Margaret Bencsik; Tom Bambino; Robert A Nissenson
Journal:  Mol Endocrinol       Date:  2002-12

8.  Regulation of receptor fate by ubiquitination of activated beta 2-adrenergic receptor and beta-arrestin.

Authors:  S K Shenoy; P H McDonald; T A Kohout; R J Lefkowitz
Journal:  Science       Date:  2001-10-04       Impact factor: 47.728

9.  Activation-independent parathyroid hormone receptor internalization is regulated by NHERF1 (EBP50).

Authors:  W Bruce Sneddon; Colin A Syme; Alessandro Bisello; Clara E Magyar; Moulay Driss Rochdi; Jean-Luc Parent; Edward J Weinman; Abdul B Abou-Samra; Peter A Friedman
Journal:  J Biol Chem       Date:  2003-08-14       Impact factor: 5.157

10.  Measurement of the millisecond activation switch of G protein-coupled receptors in living cells.

Authors:  Jean-Pierre Vilardaga; Moritz Bünemann; Cornelius Krasel; Mariàn Castro; Martin J Lohse
Journal:  Nat Biotechnol       Date:  2003-06-15       Impact factor: 54.908

View more
  217 in total

1.  Persistent cAMP signaling by thyrotropin (TSH) receptors is not dependent on internalization.

Authors:  Susanne Neumann; Elizabeth Geras-Raaka; Bernice Marcus-Samuels; Marvin C Gershengorn
Journal:  FASEB J       Date:  2010-06-10       Impact factor: 5.191

Review 2.  Role of soluble adenylyl cyclase in the heart.

Authors:  Jonathan Chen; Lonny R Levin; Jochen Buck
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-11-04       Impact factor: 4.733

Review 3.  Eosinophil crystalloid granules: structure, function, and beyond.

Authors:  Valdirene S Muniz; Peter F Weller; Josiane S Neves
Journal:  J Leukoc Biol       Date:  2012-06-06       Impact factor: 4.962

Review 4.  Allostery at G protein-coupled receptor homo- and heteromers: uncharted pharmacological landscapes.

Authors:  Nicola J Smith; Graeme Milligan
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

5.  G-protein-coupled receptor heteromer dynamics.

Authors:  Jean-Pierre Vilardaga; Luigi F Agnati; Kjell Fuxe; Francisco Ciruela
Journal:  J Cell Sci       Date:  2010-12-15       Impact factor: 5.285

Review 6.  GPCR signaling along the endocytic pathway.

Authors:  Roshanak Irannejad; Mark von Zastrow
Journal:  Curr Opin Cell Biol       Date:  2013-12-28       Impact factor: 8.382

Review 7.  Spatial control of cAMP signalling in health and disease.

Authors:  Manuela Zaccolo
Journal:  Curr Opin Pharmacol       Date:  2011-10-13       Impact factor: 5.547

Review 8.  Perspective: Implications of Ligand-Receptor Binding Kinetics for Therapeutic Targeting of G Protein-Coupled Receptors.

Authors:  Wijnand J C van der Velden; Laura H Heitman; Mette M Rosenkilde
Journal:  ACS Pharmacol Transl Sci       Date:  2020-03-18

9.  Pharmacological distinction between soluble and transmembrane adenylyl cyclases.

Authors:  Jacob L Bitterman; Lavoisier Ramos-Espiritu; Ana Diaz; Lonny R Levin; Jochen Buck
Journal:  J Pharmacol Exp Ther       Date:  2013-10-03       Impact factor: 4.030

10.  Type 10 soluble adenylyl cyclase is overexpressed in prostate carcinoma and controls proliferation of prostate cancer cells.

Authors:  Jan-Paul Flacke; Hanna Flacke; Avinash Appukuttan; Rein-Jüri Palisaar; Joachim Noldus; Brian D Robinson; H Peter Reusch; Jonathan H Zippin; Yury Ladilov
Journal:  J Biol Chem       Date:  2012-12-19       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.